Germany-Based Boehringer Ingelheim Animal Health Expands Athens-Gainesville, Georgia Facilities
02/11/2019
The Germany-based company has located its North American headquarters in Duluth, creating 75 new jobs, is adding more than 100 new jobs at its manufacturing and R&D facility in Athens; and more than 50 jobs at the company’s Gainesville manufacturing facility.
Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing, and marketing new medications of high therapeutic value for human and veterinary medicine.
“For nearly 40 years, the company and its predecessors have helped make the state of Georgia a key player in animal health, from its beginning producing rabies vaccines in Athens, to multiple facilities today, that are playing an instrumental role in advancing animal health and well-being,” said Everett Hoekstra, president of Boehringer Ingelheim Animal Health USA Inc. “Our investments will expand our capabilities and presence in Georgia, and drive future growth and innovation to help prevent disease in livestock and pets.”
“Boehringer Ingelheim is a global leader that prides itself on improving the lives of both humans and animals, and we are proud to have the Animal Health USA headquarters in Gwinnett County,” said Gwinnett County Commission Chair Charlotte Nash. “Boehringer Ingelheim recognizes that Gwinnett is a robust technology and life science hub, and that we can provide the talented workforce and vibrant connectivity they need to thrive. We look forward to their continued success in our community.”
“We’re excited to welcome Boehringer Ingelheim Animal Health USA Inc. to the Peach State,” said Governor Brian P. Kemp. “As a family-owned business, they will join a first-class corporate family here in Georgia. I look forward to working with them to strengthen our university system and existing industries in agribusiness, health technology, and science.”
“Boehringer Ingelheim is an innovative leader in the global bioscience community, with strong roots in Athens-Clarke County,” said Mayor Kelly Girtz, IDA. “This important expansion is a product of the company’s commitment to our community and the talent in Athens dating back to 1989. We look forward to an existing industry continuing to contribute to the unique vitality of Athens-Clarke County.”
“Boehringer Ingelheim has demonstrated a commitment to reinvest in the people, research, and technology that make their business a leader in life sciences and animal health,” said Mayor Danny Dunagan, City of Gainesville. “Boehringer Ingelheim’s Gainesville-Hall County location plays a key role in poultry vaccine production that is so important to animal health and prevention. This community takes great pride in being a partner with Boehringer Ingelheim and their Georgia team.”
“It’s a great day in Georgia when we can announce that a project will spur job creation in three counties,” said Georgia Department of Economic Development Commissioner Pat Wilson. “Boehringer Ingelheim’s new US animal health headquarters and dual expansions are a testament to our colleges and universities as well the resources surrounding agribusiness and veterinary sciences in Georgia.
Project Announcements
Martin Brower Plans Oshawa, Ontario, Canada, Distribution Hub
09/26/2023
Latitude Plans Clarendon County, South Carolina, Operations
09/25/2023
DePre Plans Powell, Tennessee, Production Operations
09/25/2023
Boyd Metals Expands Joplin, Missouri, Operations
09/25/2023
Books for Less Plans Westminster, South Carolina, Distribution Hub
09/25/2023
Lyon Shipyard Expands Norfolk, Virginia, Operations
09/25/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2022 Top States for Doing Business Provide an Environment for Business Growth
Q3 2022
-
Why the Southeast Is Winning EV Projects, With More on the Way
Q3 2023
-
EV Impacts to Watch in 2023 and 2024
2023 Auto/Aero Site Guide
-
Power-Intensive Site Selection
Q3 2023
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023